This maneuver indeed resulted in better tumor control without significantly affecting the number of Tregs in the TME (Supplemental Figure 11, B–F, and Supplemental Table 4), suggesting that targeting gp96 in Tregs may have therapeutic and translational potential. This evidence concerns the gene HSP90B1 and neoplasm.